← SynDRA
PENCICLOVIR
SynDRA canonical compound SYN0009007 — structure-anchored drug synonym record
| Clinical phase | Launched |
| Approval status | Approved · Rx/OTC |
| Mechanism of action | DNA directed DNA polymerase inhibitor |
| Indication | cold sore |
| Disease area | dental |
All known targets
Mechanisms of action (all sources)
- DNA directed DNA polymerase inhibitor
- Inhibitor
- TK1 INHIBITOR
Drug classes
- DNA Polymerase Inhibitors
- Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor
- Anti-Infective Agents
- Antiviral Agents
ATC classes
- J05A · DIRECT ACTING ANTIVIRALS
- D06B · CHEMOTHERAPEUTICS FOR TOPICAL USE
Cross-references
Synonyms
- denavir
- penciclovir sodium
- BRL-39123
- NSC-759624
- Denavir
- Fenistil
- Vectavir
- Penciclovirum
- Penciclovirum [INN-Latin]
- Pencyclovir
- BRL 39123
- Penciclovir [USAN:INN:BAN]
- Penciceovir
- UNII-359HUE8FJC
- CCRIS 9213
- PE2
- penciclovir (usp impurity)
- 9-(4-Hydroxy-3-(hydroxymethyl)butyl)guanine
- NSC 759624
- 9-(4-HYDROXY-3-(HYDROXYMETHYL)BUT-1-YL)GUANINE
- 9-(4-hydroxy-3-hydroxymethylbut-1-yl)guanine
- 9-(4-hydroxy-3-hydroxymethylbut-1-yl)-guanine
- 9-[4-Hydroxy-3-(hydroxymethyl)butyl]guanine
- 9-[4-hydroxy-3-(hydroxymethyl)but-1-yl]guanine
- CHEBI:7956
- DTXCID7026491
- 9-[2-hydroxy-1-(hydroxymethyl)-ethoxymethyl]guanine
- 9-(2-hydroxy-1-(hydroxymethyl)-ethoxymethyl)guanine
- RefChem:55824
- D06BB06
- J05AB13
- 2-amino-9-[4-hydroxy-3-(hydroxymethyl)butyl]-3H-purin-6-one
- MFCD00866931
- 2-amino-9-[4-hydroxy-3-(hydroxymethyl)butyl]-1H-purin-6-one
- NCGC00164630-01
- PCV
- Adenovir
- SMR000466317
Reported adverse events
- Application site reaction
- Headache
- Rash
- Pain
Look up PENCICLOVIR in the interactive SynDRA portal →